Prolactin as a goitrogenic agent in amphibia.

A. Gona

IF: 5.051

Endocrinology

Abstract:

What problem does this paper attempt to address?

Micro-Solvation of Propofol in Propylene Glycol-Water Binary Mixtures: Molecular Dynamics Simulation Studies

ANUPAMA SHARMA,Vishal Kumar,Sudip Chakraborty

DOI: https://doi.org/10.26434/chemrxiv-2023-tg83z

2023-11-03

Abstract:The water micro-structure around propofol plays a crucial role in controlling their solubility in the binary mixture. The unusual nature of such water micro-structure can influence both translational and reorientational dynamics, as well as the water hydrogen bond network near propofol. We have carried out the all atom molecular dynamics (MD) simulations of five different compositions of propylene glycol (PG): water binary mixture containing propofol (PFL) molecules to investigate the differential behavior of water micro-solvation shells around propofol, which is likely to control the propofol solubility. It is evident from the simulation snapshots for various composition that the PG at high molecular ration favors the water cluster and extended chainlike net- work that percolates within the PG matrix, where the propofol is in the disperse state. We estimated the radial distribution function indicates higher ordered water micro- structure around propofol for high PG content, as compared to the lower PG content 1in the PG:Water mixture. So, the hydrophilic propylene glycol regulates the stability of water micro-network around propofol and their solubility in the binary mixture. We observed the translational and rotational mobility of water belonging to the propofol micro-solvation shell is hindered for high propylene glycol content, and relaxed towards the low propylene glycol molecular ration in the PG:Water mixture. It has been noticed that the structural relaxation of the hydrogen bond formed between the propofol and the water molecules present in the propofol micro-solvation shell for all five compositions, is found slower for high PG content, and becomes faster on the way to low PG content in the mixture. Simultaneously, we calculated the intermittent residence time correlation function of the water molecules belonging to the micro-solvation shell around the propofol for five different compositions, and found a faster short time decay followed up with a long time components. Again, the origin of such long time decay primarily from the structural relaxation of the micro-solvation shell around the propofol, where the high propylene glycol content shows the slower structural relaxation that turns faster as the propylene glycol content approaches to the other end of the compositions. So, our studies showed that the slower structural relaxation of the micro-solvation shell around propofol for high propylene glycol molecular ration in the PG:Water mixture, correlate well with the extensive ordering of water micro-structure and restricted water mobility, facilitates the dissolution process of propofol in the binary mixture.

Chemistry
Physicochemical Characterization and Pharmacological Evaluation of Novel Propofol Micelles with Low-Lipid and Low-Free Propofol

Yongchao Chu,Tao Sun,Zichen Xie,Keyu Sun,Chen Jiang

DOI: https://doi.org/10.3390/pharmaceutics14020414

IF: 6.525

2022-01-01

Pharmaceutics

Abstract:We developed safe and stable mixed polymeric micelles with low lipids and free propofol for intravenous administration, to overcome the biological barrier of the reticuloendothelial system (RES), reduce pain upon injection, and complications of marketed propofol formulation. The propofol-mixed micelles were composed of distearoyl-phosphatidylethanolamine-methoxy-poly (ethylene glycol 2000) (DSPE mPEG2k) and Solutol HS 15 and were optimized using Box Behnken design (BBD). The optimized formulation was evaluated for globule size, zeta potential, loading content, encapsulation efficiency, pain on injection, histological evaluation, hemolysis test, in vivo anesthetic action, and pharmacokinetics, in comparison to the commercialized emulsion Diprivan. The optimized micelle formulation displayed homogenous particle sizes, and the free drug concentration in the micelles was 60.9% lower than that of Diprivan. The paw-lick study demonstrated that propofol-mixed micelles significantly reduced pain symptoms. The anesthetic action of the mixed micelles were similar with the Diprivan. Therefore, we conclude that the novel propofol-mixed micelle reduces injection-site pain and the risk of hyperlipidemia due to the low content of free propofol and low-lipid constituent. It may be a more promising clinical alternative for anesthetic.
Physicochemical Characterization and Evaluation of a Microemulsion System for Antimicrobial Activity of Glycerol Monolaurate

Xiaowei Fu,Fengqin Feng,Bin Huang

DOI: https://doi.org/10.1016/j.ijpharm.2006.05.019

IF: 6.51

2006-01-01

International Journal of Pharmaceutics

Abstract:The purpose of this study was to improve the depression, enhance the bioavailability, hence strengthen the antimicrobial ability of poorly water-soluble glycerol monolaurate (GML) by loading it in microemulsion system. Microemulsions were prepared with GML as oil, tweens as surfactant, and medium-and-short chain alcohols at different ratio as cosurfactants. The effect of the ratio of surfactant to cosurfactant on the stability of microemulsion was tested. And the effect of the composition and ratio of cosurfactant and the effect of potassium sorbate dissolved in water at different concentration on the area of O/W microemulsion region in pseudo-ternary phase diagrams were also investigated. The results showed that the microemulsion is most stable when the ratio of surfactant to cosurfactant was 3:2, the suitable cosurfactant is pentanol to dodecane at 2:1, the area of O/W microemulsion region in pseudo-ternary phase diagram increased with increasing content of potassium sorbate. The conclusion of this study was that GML loaded in microemulsion had much higher anti-microbial activity than GML alone.
In Vitro and in Vivo Evaluation of a Simple Microemulsion Formulation for Propofol

Guiling Li,Yating Fan,Xinru Li,Xiaoning Wang,Yanfang Li,Yan Liu,Mei Li

DOI: https://doi.org/10.1016/j.ijpharm.2012.01.011

IF: 6.51

2012-01-01

International Journal of Pharmaceutics

Abstract:The aim of the present study was to develop an oil-free o/w microemulsion, composed of pluronic F68, propylene glycol and saline, which solubilized poorly soluble anesthetic drug propofol for intravenous administration. The ternary diagram was constructed to identify the regions of microemulsions, and the optimal composition of microemulsion was determined by in vitro evaluation such as globule size upon dilution and rheology. The droplet size of the diluent emulsion corresponding to oil-in-water type ranged from 200 to 300nm in diameter. Stability analysis of the microemulsions indicated that they were stable upon storage for at least 6 months. Hemolysis percent of propofol microemulsions was lower than that of commercial lipid emulsion (CLE) at 4h. Acute toxicity test showed that median lethal dose of propofol microemulsion was the same as that of CLE. No significant difference in time for unconsciousness and recovery of righting reflex was observed between the prepared microemulsions and CLE. In conclusion, microemulsion would be a promising intravenous delivery system for propofol.
The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol

Mohsin Kazi,Athba Alqahtani,Majed Alharbi,Ajaz Ahmad,Muhammad Delwar Hussain,Hani Alothaid,Mohammed S. Aldughaim

DOI: https://doi.org/10.3390/molecules28031492

IF: 4.6

2023-02-03

Molecules

Abstract:Purpose: Propofol is a relatively short-acting potent anesthetic lipophilic drug used during short surgical procedures. Despite the success of propofol intravenous emulsions, drawbacks to such formulations include inherent emulsion instability, the lack of a safe vehicle to prevent sepsis, and concern regarding hyperlipidemia-related side effects. The aim of the current investigation was to develop a novel, lipid-based self-nanoemulsifying drug delivery system (SNEDDS) for propofol with improved stability and anesthetic activity for human use. Methods: A series of SNEDDS formulations were developed using naturally obtained medium-chain/long-chain mono-, di-, and triglycerides, glyceryl monocaprylate, and water-soluble cosolvents with hydrogenated castor oil constructing ternary phase diagrams for propofol. The developed SNEDDS formulations were characterized using visual observation, particle size analysis, zeta potential, transmission electron microscopy, equilibrium solubility, in vitro dynamic dispersion and stability, and in vivo sleeping disorder studies in rats. The in vivo bioavailability of the SNEDDSs in rats was also studied to compare the representative formulations with the marketed product Diprivan®. Results: Medium-chain triglycerides (M810) with mono-diglycerides (CMCM) as an oil blend and hydrogenated castor oil (KHS15) as a surfactant were selected as key ingredients in ternary phase diagram studies. The nanoemulsifying regions were identified from the studies and a number of SNEDDSs were formulated. Results from the characterization studies demonstrated the formation of efficient nanosized particles (28–45 nm globule size, 0.10–0.20 PDI) in the optimized SNEDDS with a drug loading of 50 mg/g, which is almost 500-fold higher than free propofol. TEM analysis showed the formation of spherical and homogeneous nanoparticles of less than 50 nm. The dissolution rate of the representative SNEDDS was faster than raw propofol and able to maintain 99% propofol in aqueous solution for around 24 h. The optimized liquid SNEDDS formulation was found to be thermodynamically stable. The intravenous administration of the SNEDDS in male Wistar rats induced a sleeping time of 73–88 min. The mean plasma concentrations after the IV administration of propofol nano-formulations PF2-SNEDDS and PF8-SNEDDS were 1348.07 ± 27.31 and 1138.66 ± 44.97 μg/mL, as compared to 891.44 ± 26.05 μg/mL (p = 0.05) observed after the IV administration of raw propofol. Conclusion: Propofol-loaded SNEDDS formulations could be a potential pharmaceutical product with improved stability, bioavailability, and anesthetic activity.

chemistry, multidisciplinary,biochemistry & molecular biology
Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol

Xinru Li,Yanhui Zhang,Yating Fan,Yanxia Zhou,Xiaoning Wang,Chao Fan,Yan Liu,Qiang Zhang

DOI: https://doi.org/10.1186/1556-276X-6-275

2011-01-01

Nanoscale Research Letters

Abstract:Novel mixed polymeric micelles formed from biocompatible polymers, poly(ethylene glycol)-poly(lactide) (mPEG-PLA) and polyoxyethylene-660-12-hydroxy stearate (Solutol HS15), were fabricated and used as a nanocarrier for solubilizing poorly soluble anesthetic drug propofol. The solubilization of propofol by the mixed micelles was more efficient than those made of mPEG-PLA alone. Micelles with the optimized composition of mPEG-PLA/Solutol HS15/propofol = 10/1/5 by weight had particle size of about 101 nm with narrow distribution (polydispersity index of about 0.12). Stability analysis of the mixed micelles in bovine serum albumin (BSA) solution indicated that the diblock copolymer mPEG efficiently protected the BSA adsorption on the mixed micelles because the hydrophobic groups of the copolymer were efficiently screened by mPEG, and propofol-loaded mixed micelles were stable upon storage for at least 6 months. The content of free propofol in the aqueous phase for mixed micelles was lower by 74% than that for the commercial lipid emulsion. No significant differences in times to unconsciousness and recovery of righting reflex were observed between mixed micelles and commercial lipid formulation. The pharmacological effect may serve as pharmaceutical nanocarriers with improved solubilization capacity for poorly soluble drugs.
Preparation and Property of Mpeg-Pla/pluronic Mixed Micelles and Their Role in Solubilization of Propofol

Gui-Ling Li,Xin-Ru Li,Ya-Ting Fan,Yan-Hui Zhang,Mei Li,Yan Liu

DOI: https://doi.org/10.5246/jcps.2012.03.029

2012-01-01

Journal of Chinese Pharmaceutical Sciences

Abstract:Novel mixed polymeric micelles formed by biocompatible polymers,mPEG-PLA and Pluronic P105,were fabricated and used as a nanocarrier to solubilize the poorly solublc anesthetic drug propofol.Propofol was added directly to an aqueous solution of mPEG-PLA/Pluronic P105 mixed micelles and stirred into a miccllar solution.The average particle size and size distribution of micelles were evaluated by the dynamic light scattcring technology.Drug loading content,encapsulation cfficiency and free drug concentration were determined by using ultracentrifugation and lyophilization.In vitro release characteristic of propofol formulation was investigated by dialysis method.The physical stability of mixed micelles was also assessed under storagc condition (4 ℃) after six months.Sleep-recovery studies in male Sprague-Dawley rats,at a dose of 10 mg/kg were performed to compare the pharmacodynamic profiles of propofol in mixed micelles with that of commercial lipid emulsion (CLE).The results indicated that solubilization of propofol in the mixed micelles was more efficient than that in mPEG-PLA alone.Micelles with the optimized composition of mPEG-PLA/Pluronic P105/Propofol (10∶4∶5,w/w/w) had particle size of about 90 nm with narrow distribution (polydispersity index of aboul 0.2).The content of free propofol in the aqueous phase of mixed micelles was significantly lower than that in CLE (P＜0.05).There was no remarkable differences for particle size,polydispersity index,and free drug concentration when the mix micelles were stored at 4 ℃ for six months,suggesting that the propofol-loaded mixed micelles were stable for at least six months.The accumulative release of mixed micelles was significantly higher than that of CLE at the corresponding time points,suggesting that quick release rate for mixed micelles might produce favorable pharmacological effect.No significant differences in the unconsciousness time and recovery time of righting reflex were observed between the mixed micelles and CLE (P＞0.05).In conclusion,the mixed micelle of mPEG-PLA and pluronic copolymer may be a promising candidate for intravenous delivery of propofol in clinic.
Highly water-soluble derivatives of the anesthetic agent propofol: in vitro and in vivo evaluation of cyclic amino acid esters

Cosimo Altomare,Giuseppe Trapani,Andrea Latrofa,Mariangela Serra,Enrico Sanna,Giovanni Biggio,Gaetano Liso

DOI: https://doi.org/10.1016/s0928-0987(03)00161-1

Abstract:Cyclic amino acid esters of propofol were synthesized in an attempt to develop new water-soluble anesthetic agents. Their solubility and stability in aqueous solution, and their ability to release propofol in vitro under physiological conditions were determined. L-Proline (6a) and racemic nipecotic acid (6c) esters were found to be highly soluble in water. Sufficiently stable at physiological pH (half-lives >6 h), the alpha-amino acid esters, 6a and 6b, were found to be quantitatively hydrolyzed in plasma and liver esterase solutions within a few minutes, showing prodrug behavior. The in vitro activity of the esters, determined either by the [(35)S]tert-butylbicyclophosphorothionate ([(35)S]TBPS) binding assay or electrophysiological measurements of the action at cloned human receptors, proved to be a mechanism involving allosteric modulation of GABA(A) receptors. Indeed, L-proline (6a), and racemic pipecolinate (6b) and nipecotate (6c), like propofol, reduced [(35)S]TBPS binding, whereas isonipecotate (6d) showed bicuculline-like behavior, increasing [(35)S]TBPS binding. A nonlinear relation between GABA(A) receptor binding affinity and lipophilicity, as assessed by reversed-phase high-performance liquid chromatography, emerged as a trend. The in vivo anticonvulsant and anesthetic activities of prolinate 6a, intraperitoneally administered in water solution, showed that is a water-soluble propofol prodrug candidate for developing formulations useful for parenteral administration.
Hospital Production of Sterile 2% Propofol Nanoemulsion: Proof of Concept

Amélie Cèbe,Bérangère Dessane,Pauline Gohier,Jean-Marc Bernadou,Arnaud Venet,Fabien Xuereb,Sylvie Crauste-Manciet

DOI: https://doi.org/10.3390/pharmaceutics15030905

IF: 6.525

2023-03-11

Pharmaceutics

Abstract:In the context of essential drug shortages, this article reports a proof of concept for the hospital preparation of a 2% propofol injectable nanoemulsion. Two processes for propofol were assessed: mixing propofol with the commercial Intralipid® 20% emulsion and a "de novo" process performed using separate raw materials (i.e., oil, water, and surfactant) and optimized for droplet size reduction with a high-pressure homogenizer. A propofol HPLC-UV stability-indicating method was developed for process validation and short-term stability. In addition, free propofol in the aqueous phase was quantified by dialysis. To envision routine production, sterility and endotoxin tests were validated. Only the "de novo" process using high-pressure homogenization gave satisfactory physical results similar to commercialized Diprivan® 2%. Both terminal heat sterilization processes (121 °C, 15 min and 0.22 μm filtration) were validated, but an additional pH adjustment was required prior to heat sterilization. The propofol nanoemulsion was monodisperse with a 160 nm mean droplet size, and no droplets were larger than 5μm. We confirmed that free propofol in the aqueous phase of the emulsion was similar to Diprivan 2%, and the chemical stability of propofol was validated. In conclusion, the proof of concept for the in-house 2% propofol nanoemulsion preparation was successfully demonstrated, opening the field for the possible production of the nanoemulsion in hospital pharmacies.

pharmacology & pharmacy
Transition from planar to nonplanar hydrogen bond networks in the solvation of aromatic dimers: propofol2-(H2O)(2-4)

Iker León,Judith Millán,Emilio J Cocinero,Alberto Lesarri,José A Fernández

DOI: https://doi.org/10.1021/jp401386y

2013-04-25

Abstract:Propofol (2,6-diisopropylphenol) is probably the most widely used intravenous general anesthetic. In this work, the interaction of propofol dimer with 2-4 water molecules was analyzed. The molecular aggregates were formed by using supersonic expansions, which maintain the molecules confined in a cold, collision-free environment. The clusters were then examined by using a number of mass-resolved laser-based spectroscopic techniques, including 2-color REMPI (resonance enhanced multiphoton ionization), UV/UV hole burning, and IR/UV double resonance. Two isomers were found for each stoichiometry, whose final structures were determined by comparison between the experimental data and those from density-functional-theory calculations (M06-2X/6-31+G(d)). The analysis of the observed structures allows the conclusion that the water molecules always form hydrogen bond networks, whose contribution to the cluster's total binding energy increases with the number of water molecules. In the cluster with four water molecules, the two propofol molecules lose most of their contact points. In addition, the steric hindrance produces a change from cyclic to noncyclic hydrogen bond networks earlier than in similar systems.
Lipid-free Fluoropolymer-based Propofol Emulsions and Lipid Reversal of Propofol Anesthesia in Rats

W. Tucker,C. Amlong,Colby L. Parks,S. Mecozzi,R. Pearce

DOI: https://doi.org/10.1097/ALN.0000000000001080

IF: 8.986

2016-06-01

Anesthesiology

Abstract:Background:Propofol, as a lipid-based emulsion, is effective at inducing anesthesia. It does, however, suffer from several drawbacks, including microbial growth, hyperlipidemia, and pain on injection. In this study, the authors examined the ability of four lipid-free propofol nanoemulsions to induce anesthesia in rats and tested whether a subsequent lipid bolus would accelerate emergence from anesthesia. Methods:The authors administered five formulations of propofol intravenously to six rats, delivering five different doses five times each, in a repeated-measures randomized crossover design and measured time to loss and recovery of righting reflex. The formulations included (1) Diprivan (AstraZeneca, United Kingdom); (2) L3, incorporating a semifluorinated surfactant plus egg lecithin; (3) B8, incorporating a semifluorinated surfactant only; (4) F8, incorporating a semifluorinated surfactant plus perfluorooctyl bromide; and (5) L80, incorporating egg lecithin only. In a second phase of the study, the authors administered a lipid bolus immediately after a dose of B8 or Diprivan. Results:All formulations except L80 impaired the righting reflex without apparent toxic effects. The authors estimated the threshold dose for induction by determining the x-intercept of the linear regression between time to recovery versus log dose. Threshold doses ranged from 5.8 (95% CI, 5.5 to 6.2) to 8.6 (95% CI, 7.2 to 10.2) mg/kg. A 15 ml/kg lipid bolus resulted in an accelerated clearance. Conclusions:Three of the four novel lipid-free fluoropolymer-based formulations showed efficacy in producing anesthesia, which was comparable to that of Diprivan, and a lipid bolus hastened recovery. These novel propofol formulations have the potential to avoid complications seen with the existing lipid-based formulation.

Medicine
The preclinical pharmacological study on HX0969W, a novel water-soluble pro-drug of propofol, in rats

YuJun Zhang,YingYing Jiang,HaiYan Wang,Bin Wang,Jun Yang,Yi Kang,Jun Chen,Jin Liu,Wen-sheng Zhang

DOI: https://doi.org/10.7717/peerj.8922

IF: 3.061

2020-04-16

PeerJ

Abstract:Background Propofol is the most widely used intravenous sedative-hypnotic anesthetic in clinical practice. However, many serious side effects have been related to its lipid emulsion formulation. The pro-drug design approach was used to develop the water-soluble propofol, which could effectively resolve the limitations associated with the lipid emulsion formulation. Thus, the new water-soluble pro-drug of propofol, HX0969W, was designed and synthesized. The objective of this study was to conduct preclinical pharmacological studies on this novel water-soluble pro-drug of propofol. Methods The assessment of the loss of the righting reflex (LoRR) was used for the pharmacodynamic study, and liquid chromatography-tandem mass spectrometry and high-performance liquid chromatography- fluorescence were used for the pharmacokinetic study. Results The potency of HX0969W (ED 50 [95% CI], 46.49 [43.89–49.29] mg/kg) was similar to that of fospropofol disodium (43.66 [43.57–43.75] mg/kg), but was lower than that of propofol (4.82 [4.8–14.82] mg/kg). Administered with a dose of 2-fold ED 50 , propofol required a shorter time to cause LoRR than that of HX0969W and fospropofol. However, the LoRR duration was significantly longer in response to the administration of HX0969W and fospropofol disodium than that caused by propofol. In the pharmacokinetic study, the C max of fospropofol was higher than that of HX0969W. HX0969W had a shorter mean residual time and a rapid clearance rate than that of fospropofol disodium. There was no significant difference between the T max of the propofol whether it was released by HX0969W or fospropofol disodium; the C max of propofol released by HX0969W was similar to that of propofol, which was higher than the propofol released by fospropofol disodium.

multidisciplinary sciences
Fospropofol disodium, a water-soluble prodrug of the intravenous anesthetic propofol (2,6-diisopropylphenol)

Jörg Fechner,Harald Ihmsen,Christian Jeleazcov,Jürgen Schüttler

DOI: https://doi.org/10.1517/13543780903193063

2009-09-17

Expert Opinion on Investigational Drugs

Abstract:BACKGROUND: Today, propofol or 2,6-diisopropylphenol is the anesthetic mainly used for monitored anesthetic care sedation and during intravenous anesthesia. The formulation, a lipid macroemulsion, shows several disadvantages. Therefore, during the past years considerable scientific effort has been undertaken to find either a better formulation or a prodrug of propofol. Fospropofol is the first propofol prodrug that has been intensively studied in man. It has been licensed in 2008 by the FDA for monitored anesthetic care sedation.OBJECTIVES AND METHODS: This review describes first published study results of fospropofol with regard to its pharmacokinetics/pharmacodynamics, drug safety, tolerability and drug side effects. Using a Medline search all published articles and abstracts containing the words fospropofol or GPI 15715 were included.RESULTS AND CONCLUSION: As the impact of an errorness drug assay for propofol liberated from fospropofol is not exactly defined, no clear conclusions can be drawn from the first published pharmacokinetic/pharmacodynamic studies. Fospropofol was well tolerated in the first two clinical studies and no serious side effects were reported. After characterization of the true pharmacokinetic/pharmacodynamics profile, fospropofol, an aqueous solution, has the potential to favorably compare with benzodiazepines for procedural sedation and also may be used for long-term sedation and intravenous anesthesia.

pharmacology & pharmacy
Physical and Chemical Compatibility of Etomidate and Propofol Injectable Emulsions

Chunling Wang,Shengnan Wang,Cuishuan Wu,Li Lei,Dong-Xin Wang,Qiang Zhang

DOI: https://doi.org/10.1159/000519236

IF: 3.4293

2021-01-01

Pharmacology

Abstract:Introduction: The mixture of etomidate and propofol is widely used in clinical practice to improve efficacy of general anesthesia and to minimize side effects. As a thermodynamically unstable system, emulsion is prone to destabilization through mechanisms including coalescence, flocculation, and creaming. Such unwanted phenomenon can induce fat embolism after intravenous administration. This study was aimed to investigate the physical and chemical stability of the mixture of etomidate and propofol in the dosage form of emulsion. Methods: This compatibility study focused on the critical quality attributes (CQAs) of drug-containing emulsions, such as appearance, pH, particle size and distribution, zeta potential, the observation under centrifugation, and drug content and impurity. Results: As the results, there were no significant changes in the CQAs of the mixed emulsions up to 24 h after mixing at refrigeration temperature (4°C), room temperature (25°C), and body temperature (37°C). Conclusions: These results demonstrate that etomidate emulsion is physically and chemically compatible with propofol emulsions up to 24 h at 4°C, 25°C, and 37°C, suggesting that etomidate and propofol can be administrated in mixture without adversely affecting product characteristics, at least in vitro.

pharmacology & pharmacy
Combination of a propofol emulsion with alpha-2 adrenergic receptor agonists used for multimodal analgesia or sedation in intensive care units: a physicochemical stability study

Marine Roche,Damien Rousseleau,Cécile Danel,Héloïse Henry,Gilles Lebuffe,Pascal Odou,Damien Lannoy,Nicolas Simon

DOI: https://doi.org/10.1136/ejhpharm-2023-004027

2024-01-30

European Journal of Hospital Pharmacy

Abstract:OBJECTIVES: To assess the physicochemical stability of the combination of a propofol emulsion with an alpha-2 (α2) adrenergic receptor agonist (α2A; clonidine or dexmedetomidine) under conditions mimicking routine practice in an intensive care unit or in multimodal analgesia procedures.METHODS: We developed and validated three stability-indicating methods based on high-performance liquid chromatography with ultraviolet (HPLC-UV) detection. Eight different conditions per combination were evaluated in triplicate, with variations in the simulated, bodyweight-adjusted dose level and the drugs' flow rate. The drugs were mixed in clinically relevant concentrations and proportions and then stored unprotected from light, in clear glass vials at room temperature for 96 hours. At each sampling point, we assessed the chemical stability (the HPLC-UV drug level, pH, and osmolality) and physical compatibility (visual aspect, zeta potential (ZP), mean droplet diameter (MDD, Z-average) and polydispersity index (PDI)). We validated our stability findings in positive and negative control experiments.RESULTS: Over the 96-hour test, the concentrations of propofol, clonidine and dexmedetomidine did not fall below 90% of the initial value, and the pH and osmolality were stable. The visual aspect of the mixed propofol emulsions did not change. The MDD remained below 500 nm (range 165-195 nm). The PDI was always below 0.4; 78.7% of the measurements were below 0.1 and 21.3% were between 0.1 and 0.4. The ZP measurements (-31.3 to -42.9 mV) suggested that the emulsion was stable. The MDD and PDI increased slightly at 96 hours under some conditions, which might indicate early destabilisation of the emulsion. Given that the MDD remained below 500 nm, these emulsions are compatible with intravenous administration.CONCLUSIONS: Our results demonstrate the chemical and physical compatibility of propofol-α2 agonist mixtures at concentrations and in proportions representative of standard protocols when stored unprotected from light at room temperature for 96 hours.

pharmacology & pharmacy
Design, synthesis, and activity evaluation of water-soluble propofol derivatives as anesthetic drugs

Yanxin Huang,Linyuan Zhu,Muhammad Zeeshan,Chenyang Jing,Hongji Li,Wen Li

DOI: https://doi.org/10.1016/j.bmcl.2024.129972

IF: 2.94

2024-09-22

Bioorganic & Medicinal Chemistry Letters

Abstract:In this work, two series of water-soluble derivatives were designed and synthesized based on the structure of propofol as the lead compound. Furthermore, the anesthetic activities of the synthesized compounds were evaluated in vivo against mice, and the in vitro propofol release rate from five target compounds was determined. The findings of this study have shown that series II compounds which possess the structure feature of propofol + γ-hydroxybutyric acid + α-aminoacetate or γ-aminobutyrate have higher therapeutic index than that of series I compounds which possess the structure feature of propofol + α-aminoacetate or β-aminopropionate. In addition, the rate of propofol released from series II compounds was significantly better than that of series I compounds. Among series II compounds, compound II-20 had a therapeutic index of 5.6 (propofol = 2.7), a duration time of 571 s (propofol = 57 s), and no significant toxicity was observed in vivo, which made it valuable for further development.

chemistry, medicinal, organic
Molecular Dynamics Simulation of Drug Solubilization Behavior in Surfactant and Cosolvent Injections

Meiqi He,Wenwen Zheng,Nannan Wang,Hanlu Gao,Defang Ouyang,Zunnan Huang

DOI: https://doi.org/10.3390/pharmaceutics14112366

IF: 6.525

2022-11-04

Pharmaceutics

Abstract:Surfactants and cosolvents are often combined to solubilize insoluble drugs in commercially available intravenous formulations to achieve better solubilization. In this study, six marketed parenteral formulations with surfactants and cosolvents were investigated on the aggregation processes of micelles, the structural characterization of micelles, and the properties of solvent using molecular dynamics simulations. The addition of cosolvents resulted in better hydration of the core and palisade regions of micelles and an increase in both radius of gyration (Rg) and the solvent accessible surface area (SASA), causing a rise in critical micelle concentration (CMC), which hindered the phase separation of micelles. At the same time, the presence of cosolvents disrupted the hydrogen bonding structure of water in solution, increasing the solubility of insoluble medicines. Therefore, the solubilization mechanism of the cosolvent and surfactant mixtures was successfully analyzed by molecular dynamics simulation, which will benefit future formulation development for drug delivery.

pharmacology & pharmacy
Interactive Web Simulation for Propofol and Fospropofol, a New Propofol Prodrug

Sinan Yavas,David Lizdas,Nikolaus Gravenstein,Samsun Lampotang

DOI: https://doi.org/10.1213/ane.0b013e3181614fae

2008-03-01

Abstract:Using pharmacokinetic and pharmacodynamic data published in the scientific literature, we have developed interactive on-line simulations to model administration of propofol and fospropofol, a new water-soluble prodrug formulation of propofol. The prodrug formulation of fospropofol leads to a delayed onset to peak concentrations of propofol. A comparison simulation that overlays administration of fospropofol and propofol allows clinicians to understand the differences of administering fospropofol and traditional propofol. The simulations have the added advantage of allowing for differences among patients documented in test studies and the use of different models.

anesthesiology
Mechanistic Investigation of Drug Supersaturation in the Presence of Polysorbates as Solubilizing Additives by Solution Nuclear Magnetic Resonance Spectroscopy

Xingyu Lu,Mingyue Li,Freddy A Arce,Jing Ling,Nico Setiawan,Yaqiang Wang,Xiaohuo Shi,Heather R Campbell,Matthew J Nethercott,Wei Xu,Eric J Munson,Patrick J Marsac,Yongchao Su

DOI: https://doi.org/10.1021/acs.molpharmaceut.1c00477

2021-12-06

Abstract:The introduction of solubilizing additives has historically been an attractive approach to address the ever-growing proportion of poorly water-soluble drug (PWSD) compounds within the modern drug discovery pipeline. Lipid-formulations, and more specifically micelle formulations, have garnered particular interest because of their simplicity, size, scalability, and avoidance of solid-state limitations. Although micelle formulations have been widely utilized, the molecular mechanism of drug solubilization in surfactant micelles is still poorly understood. In this study, a series of modern nuclear magnetic resonance (NMR) methods are utilized to gain a molecular-level understanding of intermolecular interactions and kinetics in a model system. This approach enabled the understanding of how a PWSD, 17β-Estradiol (E2), solubilizes within a nonionic micelle system composed of polysorbate 80 (PS80). Based on one-dimensional (1D) 1H chemical shift differences of E2 in PS80 solutions, as well as intermolecular correlations established from 1D selective nuclear Overhauser effect (NOE) and two-dimensional NOE spectroscopy experiments, E2 was found to accumulate within the palisade layer of PS80 micelles. A potential hydrogen-bonding interaction between a hydroxyl group of E2 and a carbonyl group of PS80 alkane chains may allow for stabilizing E2-PS80 mixed micelles. Diffusion and relaxation NMR analysis and particle size measurements using dynamic light scattering indicate a slight increase in the micellar size with increasing degrees of supersaturation, resulting in slower mobility of the drug molecule. Based on these structural findings, a theoretical orientation model of E2 molecules with PS80 molecules was developed and validated by computational docking simulations.
Phase behaviour of propane- and scCO(2)-microemulsions and their prominent role for the recently proposed foaming procedure POSME (Principle of Supercritical Microemulsion Expansion)

Michael Schwan,Lorenz G A Kramer,Thomas Sottmann,Reinhard Strey

DOI: https://doi.org/10.1039/b909764c

2010-06-21

Abstract:In this study we present a systematic investigation of the phase behaviour of microemulsions containing near- or supercritical solvents. The starting point of this study are microemulsions of the type water/NaCl-propane-polyethyleneglycol mono-n-alkyl ether at a pressure of p = 220 bar. Replacing propane stepwise by supercritical carbon dioxide the typical phase behavior of microemulsions systems can still be observed using scCO(2) as the only nonpolar solvent. Thus, increasing the temperature a phase inversion from a CO(2)-in-water to a water-in-CO(2) microemulsion via a balanced CO(2) microemulsion is found for the first time. Such mixtures of water and scCO(2) are expected to be versatile solvents in green chemistry. In addition, the formulation of supercritical microemulsions is the initial step in the Principle Of Supercritical Microemulsion Expansion (POSME) (DE Pat., 102 60 815 B4, 2008), which is a promising new approach for the production of low-cost nanocellular foams. In contrast to conventional foaming procedures, this approach suggests the formation of nanofoams by expanding micelles swollen with a supercritical blowing agent, thereby ensuring the unhindered formation and growth of bubbles without mass transport.

Prolactin as a goitrogenic agent in amphibia.

Micro-Solvation of Propofol in Propylene Glycol-Water Binary Mixtures: Molecular Dynamics Simulation Studies

Physicochemical Characterization and Pharmacological Evaluation of Novel Propofol Micelles with Low-Lipid and Low-Free Propofol

Physicochemical Characterization and Evaluation of a Microemulsion System for Antimicrobial Activity of Glycerol Monolaurate

In Vitro and in Vivo Evaluation of a Simple Microemulsion Formulation for Propofol

The Development and Optimization of Lipid-Based Self-Nanoemulsifying Drug Delivery Systems for the Intravenous Delivery of Propofol

Preparation and evaluation of novel mixed micelles as nanocarriers for intravenous delivery of propofol

Preparation and Property of Mpeg-Pla/pluronic Mixed Micelles and Their Role in Solubilization of Propofol

Highly water-soluble derivatives of the anesthetic agent propofol: in vitro and in vivo evaluation of cyclic amino acid esters

Hospital Production of Sterile 2% Propofol Nanoemulsion: Proof of Concept

Transition from planar to nonplanar hydrogen bond networks in the solvation of aromatic dimers: propofol2-(H2O)(2-4)

Lipid-free Fluoropolymer-based Propofol Emulsions and Lipid Reversal of Propofol Anesthesia in Rats

The preclinical pharmacological study on HX0969W, a novel water-soluble pro-drug of propofol, in rats

Fospropofol disodium, a water-soluble prodrug of the intravenous anesthetic propofol (2,6-diisopropylphenol)

Physical and Chemical Compatibility of Etomidate and Propofol Injectable Emulsions

Combination of a propofol emulsion with alpha-2 adrenergic receptor agonists used for multimodal analgesia or sedation in intensive care units: a physicochemical stability study

Design, synthesis, and activity evaluation of water-soluble propofol derivatives as anesthetic drugs

Molecular Dynamics Simulation of Drug Solubilization Behavior in Surfactant and Cosolvent Injections

Interactive Web Simulation for Propofol and Fospropofol, a New Propofol Prodrug

Mechanistic Investigation of Drug Supersaturation in the Presence of Polysorbates as Solubilizing Additives by Solution Nuclear Magnetic Resonance Spectroscopy

Phase behaviour of propane- and scCO(2)-microemulsions and their prominent role for the recently proposed foaming procedure POSME (Principle of Supercritical Microemulsion Expansion)